Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy of Januvia (Sitagliptin) in Healing Chronic Diabetic Foot Ulcers

Trial Profile

Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy of Januvia (Sitagliptin) in Healing Chronic Diabetic Foot Ulcers

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 09 Jan 2017

At a glance

  • Drugs Sitagliptin (Primary)
  • Indications Diabetic foot ulcer; Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Most Recent Events

    • 04 May 2015 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov record.
    • 07 Apr 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
    • 24 Dec 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top